GH Research GHRS
$17.53 −$1.03 (-5.55%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $17.53 0.00%
Open$18.32
Prev close$18.56
Day range$17.29 – $18.32
Volume299.5K
Market cap$1.20B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$0.00
Operating profit-$19.45M-32.4% YoY
Net profit-$15.15M-63.1% YoY
Diluted EPS-$0.23-53.3% YoY
Free cash flow-$15.04M-66.6% YoY
Operating cash flow-$15.02M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-18.8%
Return on assets-18.2%
Return on invested capital-19.8%
Current ratio28.70
Liabilities / assets3.5%
Cash & investments$362.65M
Total debt$6,000.00
Net cash (debt)$362.64M
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $19.45M | $18.75M | $60.68M | $16.70M | $16.54M |
| Selling and Admin Expenses | $7.06M | $6.37M | $21.65M | $5.25M | $5.92M |
| -General & Admin Expense | $7.06M | $6.37M | $21.65M | $5.25M | $5.92M |
| Research & Development | $12.40M | $12.38M | $38.77M | $11.39M | $10.57M |
| Asset Impairment Loss | -$7,000.00 | -$1,000.00 | -$42,000.00 | -$18,000.00 | -$30,000.00 |
| Operating Profit | -$19.45M | -$18.75M | -$60.68M | -$16.70M | -$16.54M |
| Net Non-Operating Interest Income (Expense) | $966,000.00 | $582,000.00 | $4.62M | $722,000.00 | $980,000.00 |
| Non-Operating Interest Income | $1.05M | $666,000.00 | $5.08M | $812,000.00 | $1.00M |
| Non-Operating Interest Expense | $6,000.00 | $6,000.00 | $35,000.00 | $8,000.00 | $8,000.00 |
| Total Other Finance Costs | $77,000.00 | $78,000.00 | $428,000.00 | $82,000.00 | $13,000.00 |
| Other Income (Expense) | $3.34M | -$801,000.00 | $7.80M | $1.84M | $1.54M |
| Gain on Sale of Security | $3.34M | -$801,000.00 | $7.80M | $1.84M | $1.54M |
| Pretax Profit | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Profit | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| Profit from Continuing Operations | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| Net Income to Parent Company | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| Net Income to Common Stockholders | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| Basic EPS | -$0.23 | -$0.31 | -$0.79 | -$0.23 | -$0.23 |
| Diluted EPS | -$0.23 | -$0.31 | -$0.79 | -$0.23 | -$0.23 |
| Depreciation & Amortization & Depletion | – | – | $302,000.00 | $78,000.00 | $79,000.00 |
| -Depreciation & Amortization | – | – | $302,000.00 | $78,000.00 | $79,000.00 |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $372.35M | $275.27M | $288.23M | $288.23M | $302.02M |
| Total Current Assets | $368.82M | $272.23M | $285.98M | $285.98M | $294.79M |
| Cash and Cash Equivalents & Short-Term Investments | $362.65M | $267.33M | $280.71M | $280.71M | $288.51M |
| -Cash and Cash Equivalents | $345.05M | $242.65M | $246.25M | $246.25M | $249.65M |
| -Short Term Investments | $17.60M | $24.67M | $34.46M | $34.46M | $38.85M |
| Other Current Assets | $6.17M | $4.91M | – | – | $6.28M |
| Total Non-Current Assets | $3.53M | $3.04M | $2.25M | $2.25M | $7.23M |
| Net PPE | $502,000.00 | $580,000.00 | $620,000.00 | $620,000.00 | $692,000.00 |
| Other Non-Current Assets | $3.02M | $2.46M | – | – | – |
| Total Liabilities | $12.86M | $11.89M | $8.53M | $8.53M | $10.63M |
| Total Current Liabilities | $12.85M | $11.82M | $8.38M | $8.38M | $10.41M |
| Payables | $5.93M | $5.21M | $4.27M | $4.27M | $3.84M |
| -Accounts Payable | $5.93M | $5.21M | $3.77M | $3.77M | $3.84M |
| Short-Term Debt and Capital Lease Obligation | $354,000.00 | $357,000.00 | $365,000.00 | $365,000.00 | $365,000.00 |
| -Current Capital Lease Obligation | $354,000.00 | $357,000.00 | $365,000.00 | $365,000.00 | $365,000.00 |
| Other Current Liabilities | $6.57M | $6.25M | $407,000.00 | $407,000.00 | $6.21M |
| Total Non-Current Liabilities | $6,000.00 | $75,000.00 | $147,000.00 | $147,000.00 | $217,000.00 |
| Long Term Debt and Capital Lease Obligation | $6,000.00 | $75,000.00 | $147,000.00 | $147,000.00 | $217,000.00 |
| -Long Term Capital Lease Obligation | $6,000.00 | $75,000.00 | $147,000.00 | $147,000.00 | $217,000.00 |
| Total Equity | $359.49M | $263.38M | $279.70M | $279.70M | $291.40M |
| Stockholders' Equity | $359.49M | $263.38M | $279.70M | $279.70M | $291.40M |
| Capital Stock | $1.72M | $1.55M | $1.55M | $1.55M | $1.55M |
| -Common Stock | $1.72M | $1.55M | $1.55M | $1.55M | $1.55M |
| Additional Paid-In Capital | $542.67M | $431.13M | $431.06M | $431.06M | $431.06M |
| Retained Earnings | -$187.84M | -$173.23M | -$154.43M | -$154.43M | -$140.29M |
| Gains/Losses Not Affecting Retained Earnings | $2.94M | $3.92M | $1.52M | $1.52M | -$927,000.00 |
| Receivables | – | – | $1.30M | $1.30M | – |
| -Taxes Receivable | – | – | $137,000.00 | $137,000.00 | – |
| -Other Receivables | – | – | $1.16M | $1.16M | – |
| Prepaid Assets | – | – | $3.97M | $3.97M | – |
| -Gross PPE | – | – | $1.68M | $1.68M | – |
| -Accumulated Depreciation | – | – | -$1.06M | -$1.06M | – |
| Investments and Advances | – | – | $0.00 | $0.00 | $5.38M |
| Non Current Accounts Receivables | – | – | $1.63M | $1.63M | $1.16M |
| -Other Payable | – | – | $495,000.00 | $495,000.00 | – |
| Current Accrued Expenses | – | – | $3.34M | $3.34M | – |
| -Available for Sale Securities | – | – | – | – | $5.38M |
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$15.02M | -$10.67M | -$43.55M | -$12.33M | -$13.68M |
| Net cash flow from continuing operations | -$15.02M | -$10.67M | -$43.55M | -$12.33M | -$13.68M |
| Net Income from Continuing Operations | -$15.15M | -$18.97M | -$48.26M | -$14.14M | -$14.02M |
| Gain/Loss from Continuing Operations | -$1.73M | $2.33M | -$1.75M | -$140,000.00 | $247,000.00 |
| Depreciation & Depletion & Amortization | $91,000.00 | $91,000.00 | $335,000.00 | $88,000.00 | $89,000.00 |
| Other Non-Cash Items | -$2.57M | -$2.11M | -$10.67M | -$2.42M | -$2.76M |
| Change in Working Capital | -$845,000.00 | $2.96M | -$3.09M | -$1.56M | -$2.90M |
| Net cash flow from investing | $6.34M | $8.64M | $46.17M | $8.84M | $9.78M |
| Net Cash Flow from Continuing Investing Activities | $6.34M | $8.64M | $46.17M | $8.84M | $9.78M |
| Net PPE Purchase and Sale | -$17,000.00 | -$63,000.00 | -$121,000.00 | -$19,000.00 | -$39,000.00 |
| Net Investment Purchase and Sale | $6.36M | $8.70M | $46.29M | $8.86M | $9.82M |
| Financing Cash Flow | $111.87M | $2,000.00 | $139.65M | -$68,000.00 | -$66,000.00 |
| Net Cash Flow from Continuing Financing Activities | $111.87M | $2,000.00 | $139.65M | -$68,000.00 | -$66,000.00 |
| Net Issuance Payments Of Debt | -$71,000.00 | -$70,000.00 | -$197,000.00 | -$68,000.00 | -$66,000.00 |
| Net Common Stock Issuance | $117.97M | $72,000.00 | $150.00M | $0.00 | $0.00 |
| Ending Cash Balance | $345.05M | $242.65M | $246.25M | $246.25M | $249.65M |
| Net Change in Cash | $103.19M | -$2.03M | $142.27M | -$3.56M | -$3.96M |
| Beginning Cash Balance | $242.65M | $246.25M | $100.79M | $249.65M | $253.87M |
| Effect of Exchange Rate Changes | -$789,000.00 | -$1.57M | $3.19M | $155,000.00 | -$255,000.00 |
| Free Cash Flow | -$15.04M | -$10.73M | -$43.67M | -$12.35M | -$13.72M |
| Net Other Financing Charges | – | – | -$10.15M | $0.00 | $0.00 |
No comments yet — be the first to weigh in on GHRS.
Sign in to join the discussion.